Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of rate gouging, pointing out the stark distinction in between U.S. costs and people in Europe and copyright.This led Novo Nordisk to perform even more investigation into larger dosages of semaglutide specifical